Share on StockTwits

Equities research analysts at Goldman Sachs boosted their price objective on shares of PerkinElmer (NYSE:PKI) from $53.00 to $54.00 in a research note issued to investors on Friday, American Banking & Market News reports. Goldman Sachs’ price target indicates a potential upside of 22.64% from the stock’s previous close.

A number of other analysts have also recently weighed in on PKI. Analysts at Wells Fargo & Co. downgraded shares of PerkinElmer from a “neutral” rating to an “underperform” rating in a research note on Wednesday. They now have a $49.00 price target on the stock. They noted that the move was a valuation call. Separately, analysts at ISI Group downgraded shares of PerkinElmer from a “buy” rating to a “neutral” rating in a research note on Wednesday. They now have a $49.00 price target on the stock. Finally, analysts at EVA Dimensions upgraded shares of PerkinElmer from an “underweight” rating to a “hold” rating in a research note on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. PerkinElmer currently has a consensus rating of “Hold” and an average target price of $42.43.

Shares of PerkinElmer (NYSE:PKI) traded down 1.37% on Friday, hitting $43.80. The stock had a trading volume of 715,292 shares. PerkinElmer has a 52-week low of $29.50 and a 52-week high of $46.72. The stock’s 50-day moving average is $45.14 and its 200-day moving average is $41.16. The company has a market cap of $4.943 billion and a price-to-earnings ratio of 30.13.

PerkinElmer (NYSE:PKI) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.73 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.70 by $0.03. The company had revenue of $594.00 million for the quarter, compared to the consensus estimate of $588.95 million. Analysts expect that PerkinElmer will post $2.45 EPS for the current fiscal year.

In other PerkinElmer news, Insider James Corbett sold 22,027 shares of the stock on the open market in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $45.11, for a total value of $993,637.97. Following the sale, the insider now directly owns 21,858 shares of the company’s stock, valued at approximately $986,014. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.